Mercer Global Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
21,811
-2,006
-8% -$171K ﹤0.01% 1432
2026
Q1
$2.05M Buy
23,817
+18,101
+317% +$1.62M ﹤0.01% 1188
2025
Q4
$499K Buy
+5,716
New +$434K ﹤0.01% 1864
2023
Q4
Sell
-4,206
Closed -$209K 2041
2023
Q3
$209K Buy
+4,206
New +$235K ﹤0.01% 1740
2023
Q1
Sell
-3,116
Closed -$231K 1987
2022
Q4
$231K Buy
+3,116
New +$212K ﹤0.01% 1637

Other funds holding GMED

Mercer Global Advisors's GMED Position: Q2 2026 in Review

Mercer Global Advisors reduced its Globus Medical (GMED) stake by 8.4% in Q2 2026, selling an estimated $171K and leaving 21,811 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Mercer Global Advisors first reported a position in GMED in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.05M in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Mercer Global Advisors held 21,811 shares of Globus Medical worth $1.72M as of Q2 2026.
  • Mercer Global Advisors sold 2,006 Globus Medical shares in Q2 2026, an estimated $171K.
  • Globus Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1432 holding.
  • Mercer Global Advisors first reported a position in Globus Medical in Q4 2022 and has held it in 5 quarters since.
  • Mercer Global Advisors's Globus Medical position peaked at $2.05M in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.